Micro-Caps Chase Overseas Growth as Domestic Markets Stagnate

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Hong Kong micro-caps turned to overseas markets as domestic headwinds intensified. FDB Holdings (1826.HK) surged 17% after securing a $11.8 million EPC contract for a 4.5MW natural gas plant in Kazakhstan—funds partly drawn from rights issue proceeds. Forest Cabin (2657.HK) accelerated Hong Kong expansion with East Point City flagship store opening, backed by four consecutive days of share buybacks totaling HK$31.6 million. CStone Pharma-B (2616.HK) gained UK approval for Sugemalimab, with CEO Yang Jianxin adding 496,000 shares in September. DZUG (1635.HK) committed RMB 214.5 million to environmental fund investments while maintaining AA- ESG rating. Man Shun Group (1746.HK) disclosed ongoing negotiations for potential control transfer under Hong Kong Takeovers Code. Universe Ent (1046.HK) plunged 20.3% following FY2026 revenue collapse of 74.6%. Heng Xinfeng (1920.HK) posted 13.6% revenue growth with new beauty segment contribution. Weili Holdings (2372.HK) saw unexplained 23.9% single-day plunge on October 13. Chunli Medical (1858.HK) prepares Q3 results announcement with Morgan Stanley raising stake to 5%. HYGIEIA GROUP (1650.HK) maintained steady 8% revenue growth in Singapore waste management sector.

Source: Global Report The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.